Richard C. Woodman

Richard C. Woodman

Directeur/Bestuurslid bij
H3 Biomedicine, Inc.
71 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Richard C.
Woodman
is currently the Director at H3 Biomedicine, Inc. He previously worked as the Senior Director-Medical at Johnson & Johnson from 2002 to 2006, and as the Head-US Oncology Clinical Development at Novartis, Inc. from 2006 to 2018.
He also served as the Chief Clinical Officer-Oncology Business Group at Eisai Co., Ltd. and as the Chief Medical Officer, SVP-Research & Development at Onconova Therapeutics, Inc. from 2018 to 2021.
Prior to his industry career, he was a Professor at the University of Calgary.
Woodman received his undergraduate degree from the University of British Columbia and his doctorate from the University of Calgary in 1981.

Actieve functies van Richard C. Woodman

BedrijvenFunctieBegin
Directeur/Bestuurslid 11-01-2022

Eerdere bekende functies van Richard C. Woodman

BedrijvenFunctieEinde
TRAWS PHARMA, INC. Hoofd Techniek/Wetenschap/O&O 15-01-2021
Hoofd Techniek/Wetenschap/O&O 01-03-2018
JOHNSON & JOHNSON Corporate Officer/Principal 01-01-2006
EISAI CO., LTD. Corporate Officer/Principal -
Corporate Officer/Principal -
Ervaring van Richard C. Woodman in detail bekijken

Opleiding van Richard C. Woodman

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

78

Eerstegraads connecties

7

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit7

Health Technology

Health Technology

Commercial Services

Health Technology

Consumer Services

Consumer Services

Commercial Services

  1. Beurs
  2. Insiders
  3. Richard C. Woodman
DE LAATSTE UREN | -40 %: De beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU